Faculty Publications

Health Policy Research Institute faculty members are active contributors to a wide range of journal publications.

View the most recent publications for each faculty member below.

Dr. Sheldon Greenfield »
  • Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Chen VW, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Kaplan SH, Paddock LE, Stroup AM, Wu XC, Koyama T, Penson DF.  Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.  Cancer. 2014 Apr 15;120(8):1263-71. (PMID: 24510400)

  • Brenneman SK, Shene W, Brekke L, Paczowski R, Bancroft T, Kaplan SH, Greenfield S, Berger M, Buesching DP.  Field-testing the ENSEMBLE Minimum Dataset: performance of an instrument to address heterogeneity of treatment effects. J Comp Eff Res. 2014 Sep;3(5):463-72. (PMID: 25350798)

  • Nguyen H, Sorkin DH, Billimek J, Kaplan SH, Greenfield S, Ngo-Metzger Q. Complementary and alternative medicine (CAM) use among non-Hispanic white, Mexican American, and Vietnamese American patients with type 2 diabetes.  J Health Care Poor Underserved. 2014 Nov;25(4):1941-55. (PMID: 25418251)

  • Daskivich T, Kwan L, Dash A, Greenfield S, Litwin M. Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer.  Eur Urol. 2014 Dec;66(6):1002-9. (PMID: 24924554)

  • Billimek J, Malik S, Sorkin DH, Schmalbach P, Ngo-Metzger Q, Greenfield S, Kaplan SH.  Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification. Womens Health Issues. 2015 Jan-Feb;25(1):6-12. (PMID: 25442365)

  • Choi SE, Ngo-Metzger Q, Billimek J, Greenfield S, Kaplan SH, Sorkin DH. Contributors to patients’ ratings of quality of care among ethnically diverse patients with type 2 diabetes. J Immigr Minor Health. 2015 Mar 5. [Epub ahead of print]

  • Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF.  The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol. 2015 Jun;67(6):1019-25. (PMID: 25174325)

  • Hidas G, Billimek J, Nan A, Wehbi E, Watts B, Pribish M, Tandis S, McAleer I, McLorie G, Greenfield S, Kaplan SH, Khoury AE.  Predicting the Risk for Breakthrough Urinary Tract Infection in Children with Primary Vesicoureteral Reflux. J Urol. 2015 Jun 9. [Epub ahead of print] (PMID: 26066405)

  • Sorkin DH, Billimek J, August KJ, Ngo-Metzger Q, Kaplan SH, Reikes AR, Greenfield S.  Mental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes, Fam Pract. 2015 Jun;32(3):317-22. (PMID: 25846216)

  • Cannesson M, Ramsingh D, Rinehart J, Demirjian A, Vu T, Vakharia S, Imagawa D, Yu Z, Greenfield S, Kain S. Perioperative goal-directed therapy and postoperative outcomes in patients undergoing high-risk abdominal surgery: A historical-perspective, comparative effectiveness study. Crit Care. 2015 Jun 19;19:261. (PMID: 26088649)

Dr. Sherrie H. Kaplan »
  • Jenkins BN, Fortier MA, Kaplan SH, Mayes LC, Kain ZN. Development of a short version of the modified Yale preoperative anxiety scale. Anesth Analg. 2014 Sep;119(3):643-50. (PMID: 25010821)

  • Brenneman SK, Shene W, Brekke L, Paczowski R, Bancroft T, Kaplan SH, Greenfield S, Berger M, Buesching DP. Field-testing the ENSEMBLE Minimum Dataset: performance of an instrument to address heterogeneity of treatment effects. J Comp Eff Res. 2014 Sep;3(5):463-72. (PMID: 25350798)

  • Amin AN, Tucker S, Hofmann H, Kaplan SH. Reduce Readmissions with Service-based Care Management. Prof Care Manag. 2014 Nov-Dec;19(6):255-62. (PMID: 25271943)

  • Nguyen H, Sorkin DH, Billimek J, Kaplan SH, Greenfield S, Ngo-Metzger Q. Complementary and alternative medicine (CAM) use among non-Hispanic white, Mexican American, and Vietnamese American patients with type 2 diabetes. J Health Care Poor Underserved. 2014 Nov;25(4):1941-55. (PMID: 25418251)

  • Billimek J, Malik S, Sorkin DH, Schmalbach P, Ngo-Metzger Q, Greenfield S, Kaplan SH. Understanding Disparities in Lipid Management among Patients with Type 2 Diabetes: Gender Differences in Medication Nonadherence Following Treatment Intensification. Womens Health Issues. 2015 Jan-Feb;25(1):6-12. (PMID: 25442365)

  • Choi SE, Ngo-Metzger Q, Billimek J, Greenfield S, Kaplan SH, Sorkin DH. Contributors to patients’ ratings of quality of care among ethnically diverse patients with type 2 diabetes, J Immigr Minor Health. 2015 Mar 5. [Epub ahead of print]

  • Sorkin DH, Billimek J, August KJ, Ngo-Metzger Q, Kaplan SH, Reikes AR, Greenfield S.  Mental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes, Fam Pract. 2015 Jun;32(3):317-22. (PMID: 25846216)

  • Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF.  The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research. Eur Urol. 2015 Jun; 67(6):1019-25. (PMID: 25174325)

  • Hidas G, Billimek J, Nan A, Wehbi E, Watts B, Pribish M, Tandis S, McAleer I, McLorie G, Greenfield S, Kaplan SH, Khoury AE.  Predicting the Risk for Breakthrough Urinary Tract Infection in Children with Primary Vesicouteral Reflux. J Urol. 2015 Jun 9. [Epub ahead of print] (PMID: 26066405)

  • Jenkins BN, Kain ZN, Kaplan SH, Stevenson RS, Mayes LC, Guadarrama J, Fortier MA.  Revisiting a measure of child postoperative recovery: development of the Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS). Paediatr Anaesth. 2015 Jul;25(7):738-745. 

Dr. John Billimek »
  • Huntsman MA, Olivares FJ, Tran CP, Billimek J, Hui Ee.  Pain Reduction and Financial Incentives to Improve Glucose Monitoring Adherence in a Community Health Center. PLoS One. 2014, 9(12):e114875. (PMID: 25486531)

  • Choi SE, Ngo-Metzger Q, Billimek J, Greenfield S, Kaplan SH, Sorkin DH. Contributors to patients' ratings of quality of care among ethnically diverse patients with type 2 diabetes. J Immigr Minor Health. 2015 Mar 5. [Epub ahead of print]

  • Datta R, Kazerouni NN, Rosenberg J, Nguyen VQ, Phelan M, Billimek J, Cao C, McLendon P, Cummings K, Huang SS. Substantial Variation in Hospital Rankings after Adjusting for Hospital-Level Predictors of Publicly-Reported Hospital-Associated Clostridium difficile Infection Rates. Infect Control Hosp Epidemiol. 2015 Apr;36(4):464-6. (PMID: 25782902)

  • Sorkin DH, Billimek J, August KJ, Ngo-Metzger Q, Kaplan SH, Reikes AR, Greenfield S. Mental Health Systems and Patient-Reported Diabetes Symptom Burden: Implications for Medication Regimen Changes. Fam Pract. 2015 Jun;32(3):317-22. (PMID: 25846216)

  • Billimek J, Guzman H, Angulo MA. Effectiveness and feasibility of a software tool to help patients communicate with doctors about problems they face with their medication regimen (EMPATHy): study protocol for a randomized controlled trial. Trials. 2015, 16(1):145. (PMID: 25873349)
  • Hidas G, Billimek J, Nan A, Soltani T, Wehbi E, Watts B, Pribish M, McAleer I, McLorie G, Greenfield S, Kaplan SH, Khoury AE.  Predicting the risk for breakthrough urinary tract infections in children with primary vesicoureteral reflux. J Urol. 2015 [EPub ahead of print]. (PMID: 26066405)

  • August KJ, Billimek J. A Theoretical Model of How Neighborhood Factors Contribute to Medication Nonadherence AMong Disadvantaged Chronically-Ill Adults. J Health Psychol. 2015 Jun 17. [Epub ahead of print] (PMID: 26089191)

  • Soltani T, Hidas G, Kelly MS, Kaplan A, Selby B, Billimek J, Wehbi E, McDougall E, McAleer I, McLorie G, Khoury AE. Endoscopic correction of vesicoureteral reflux simulator curriculum as an effective teaching tool: Pilot study. J Pediat Urol. 2015 Aug 19. [Epub ahead of print] (PMID: 26350643)

  • Datta R, Brown S, Nguyen VQ, Cao C, Billimek J, Avery T, Lee BY, Huang SS. Quantifying the Exposure to Antibiotic-Resistant Pathogens Among Patients Discharged From a Single Hospital Across All California Healthcare Facilities. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1275-82. [Epub ahead of print]. (PMID: 26387690)

  • Sorkin D, Biegler KA, Billimek J. Differences in Self-Reported Physical Activity and Body Mass Index Among Older Hispanic and Non-Hispanic White Men and Women: Findings from the 2009 California Health Interview Survey. J Am Geriatr Soc. 2015 Oct;63(10):2158-63. [Epub ahead of print] (PMID: 26416708)

Dr. Susan Huang »
  • Hudson LO, Murphy CR, Spratt BG, Enright MC, Quan V, Kim D, Hannah P, Mikhail L, Alexander R, Moore DF, Godoy D, Bishop CJ, Huang SS. Diversity of Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Isolated from Residents of 26 Nursing Homes in Orange County, California. J Clin Microbiol. 2015. In press.
  • Quan KA, Cousins SM, Porter DD, Puppo RA, Huang SS. Automated Tracking and Ordering of Precautions for Multi-Drug Resistant Organisms (MDRO). Am Journal Infect Control. 2015. In press.
  • Ye Z, Mukamel DB, Huang SS, Li Y, Temkin-Greener H. Nursing Home Prevalence, Policies, and Practices Associated with Healthcare-Associated Pathogens: Results from a National Survey. Infect Control Hosp Epidemiol. 2015. In press.
  • Datta R, Brown S, Nguyen VQ, Cao C, Billimek J, Avery T, Lee BY, Huang SS. Quantifying the Exposure to Antibiotic-Resistant Pathogens among Patients Discharged from a Single Hospital across all California Healthcare Facilities. Infect Control Hosp Epidemiol. 2015. In press.
  • Gohil SK, Datta R, Cao C, Phelan MJ, Nguyen V, Rowther SS, Huang SS. Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates. Clin Infect Dis. In revision.
Dr. Lari Wenzel »
  • Donovan HS, Nolte S, Edwards RP, Wenzel L. Nursing Research in the Gynecologic Oncology Group. Semin Oncol Nurs. 2014 Feb;30(1):44-52. (PMID: 24559780)

  • Donovan K, Donovan H, Cella D, Gaines M, Penson R, Plaxe S, von Gruenigen V, Bruner D, Reeve B, Wenzel L. Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials. J Natl Cancer Inst. 2014 Jul;106(7). (PMID: 25006190)

  • Osann K, Hsieh S, Nelson E, Monk B, Chase D, Cella D, Wenzel L. Factors Associated with Poor Quality of Life among Cervical Cancer Survivors: Implications for Clinical Care and Clinical Trials. Gynecol Oncol. 2014 Nov;135(2):266-72. (PMID: 25192629)

  • Pfaendler K, Wenzel L, Mechanic M, Penner K. Cervical cancer survivorship: Long-term quality of life and social support. Clin Ther. 2015 Jan;37(1):39-48. (PMID: 25592090)

  • Cohn D, Barnett J, Wenzel L, Monk B, Burger R, Straughn M, Myers E, Havrilesky L. A cost-utility utility analysis of an NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality of life scores in an economic model of treatment of ovarian cancer. Gynecol Oncol. 2015 Feb;136(2):293-9. (PMID: 25449568)

  • Wenzel L, Osann K, Hsieh S, Tucker J, Monk B, Nelson E. Psychosocial Telephone Counseling for Cervical Cancer Survivors: Results of a Randomized Biobehavioral Trial. J Clin Oncol. 2015 Apr;33(10):1171-9. (PMID: 25713429)

  • Penson R, Huang H, Wenzel L, Monk B, Stockman S, Long H, Ramondetta L, Landrum L, Oaknin A, Reid T, Leitao M, Method M, Michael H, Tewari K. Patient Reported Outcomes in a Practice Changing Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: An NRG Oncology/Gynecologic Oncology Group Study. Lancet Oncol. 2015 Mar;16(3):301-11. (PMID: 25638326)

  • Chase D, Huang H, Foss C, Wenzel L, Monk BJ, Burger R. Neurotoxicity in ovarian cancer patients on Gynecologic Oncology Group (GOG) protocol 218: Characteristics associated with toxicity and the effect of substitution with docetaxel: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2015 Feb;36(2):323-7. (PMID: 25529832)

  • Chase D, Kauderer J, Wenzel L, Ramondetta L, Cella D, Long H, Monk BJ. Factors Associated with Grade 3 or 4 Treatment-related Toxicity in Women with Advanced or Recurrent Cervical Cancer: An Exploratory Analysis of NRG Oncology/Gynecologic Oncology Group Trials 179 and 204. Int J Gynecol Cancer. 2015 Feb;25(2):303-8. (PMID: 25405577)

  • Havrilesky LJ, Osann K, Lipscomb J, Hsieh S, Walker JL, Wright AA, Alvarez RD, Karlan BY, Bristow RE, DiSilvestro PA, Wakabayashi MT, Morgan R, Mukamel DB, Wenzel L.  Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practice. Gynecol Oncol. 2015 Sep;138(3):712-6. (PMID: 26177553)